These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7796776)

  • 21. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of hepatitis Be antigen and anti-HBE in adults in Benin City.
    Abiodun PO; Olomu A; Okolo SN; Obasohan A; Freeman O
    West Afr J Med; 1994; 13(3):171-4. PubMed ID: 7841109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of alcohol on the liver in HBsAg carriers.
    Itoh S; Shimoji K
    Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors.
    Neriishi K; Akiba S; Amano T; Ogino T; Kodama K
    Radiat Res; 1995 Nov; 144(2):215-21. PubMed ID: 7480648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive.
    Brown SD; Barbara AJ; Lambert T; Wilson DV
    Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia.
    Al-Sebayel MI; Khalaf HA; Ramirez CG
    Saudi Med J; 2002 Mar; 23(3):298-300. PubMed ID: 11938420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-invasive assessment of hepatitis B virus carrier status using saliva samples.
    Richards AL; Perrault JG; Caringal LT; Manaloto CR; Sie A; Graham R; Ramos RM; Leonardo JB; Hyams KC
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):80-4. PubMed ID: 9031406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
    Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria.
    Otegbayo JA; Fasola FA; Abja A
    Trop Gastroenterol; 2003; 24(4):196-7. PubMed ID: 15164531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis B surface antigen among patients suspected of liver diseases in a Nigerian hospital.
    Baba MM; Ajayi BB; Ekanem IA
    Niger Postgrad Med J; 2000 Sep; 7(3):91-5. PubMed ID: 11257921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours.
    Alexopoulos CG; Vaslamatzis M; Hatzidimitriou G
    Br J Cancer; 1999 Sep; 81(1):69-74. PubMed ID: 10487614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B infection in households of HBsAg positive New Zealand children.
    Martin AR; Moyes CD; Lucas CR; Milne A
    N Z Med J; 1996 Dec; 109(1035):463-5. PubMed ID: 9006626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B virus among chronic schizophrenia patients.
    Said WM; Saleh R; Jumaian N
    East Mediterr Health J; 2001 May; 7(3):526-30. PubMed ID: 12690775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part II: Evaluation of epidemiological factors and suspected risk factors of liver dysfunction.
    Shiina S; Fujino H; Kawabe T; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y
    Am J Gastroenterol; 1991 Jul; 86(7):872-5. PubMed ID: 2058630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.